Key facts
- Notable investors include Medex Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Provital
- ·The full record, as it builds
Funding rounds
No funding rounds for Provital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Provital
Manufacturer of cosmetic active ingredients designed for skincare and haircare applications. The company develops plant-based and biotechnology-derived ingredients, integrates scientific research with natural extracts, conducts efficacy and safety studies, ensures compliance with sustainability and ethical sourcing standards, offers a catalog of functional actives for hydration, hair growth, sebum control, and skin protection, and maintains transparency across its supply chain, enabling cosmetics manufacturers and formulators to create products with verified performance, environmental consideration, and consistent quality.
- Sector
- Materials and Resources
- HQ
- Barcelona, Spain
- Founded
- 1979
- Employees
- 181
- Website
- weareprovital.com/
- Ownership
- Privately Held (backing)
Provital doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Provital shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Provital in its N-PORT filings yet. We sweep new filings monthly.